Filing Details
- Accession Number:
- 0001437749-12-003218
- Form Type:
- 5/A
- Zero Holdings:
- No
- Publication Time:
- 2012-04-02 14:17:30
- Reporting Period:
- 2007-10-25
- Filing Date:
- 2012-04-02
- Accepted Time:
- 2012-04-02 13:17:30
- Original Submission Date:
- 2012-02-13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1389545 | Novabay Pharmaceuticals Inc. | NBY | Pharmaceutical Preparations (2834) | 680454536 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1532040 | W. David Stroman | C/O Novabay Pharmaceuticals, Inc. 5980 Horton Street, Suite 550 Emeryville CA 94608 | Svp, Ophthalmic Product Devt. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2007-10-25 | 2,000 | $4.00 | 2,000 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct |
Footnotes
- Dr. Stroman purchased 2,000 Common shares at the Company's IPO in October 2007 and he was not an employee of the Company at the time of the purchase. Dr. Stroman joined the Company in October 2011.